| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $122K | -50.5% |
| Operating Income | $11.5M | — |
| Net Income | -$239K | +33.9% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4K | -88.1% |
| Current Assets | $4K | -90.3% |
| Total Assets | $4K | -90.3% |
| Current Liabilities | $365K | +23.8% |
| Total Liabilities | $365K | +23.8% |
| Stockholders' Equity | -$361K | -43.3% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64K | +21.3% |
| Financing Cash Flow | $33K | — |